CAR T cell therapy (Regeneron Pharmaceuticals/JW Therapeutics)

N/A

Report date: 2025/06/11 10:59:14

Base Information

Drug NameCAR T cell therapy (Regeneron Pharmaceuticals/JW Therapeutics)
Drug Alias NameCAR T cell therapy (2Seventy Bio)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator Companies2seventy Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesJw Therapeutics (Shanghai) Co LtdRegeneron Pharmaceuticals Inc
Inactive Companies2seventy Bio Inc
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A